Member Info for G-Man11

Quite clearly folk taking money out to jump on to another riser, most likely #mka.

Certainly nothing leaky that I can see. Quite normal.

A sentiment buy for me. Trump wants Greenlands Assets, Denmark has Greenlands assets and this company are positioned to benefit from Greenlands assets.

This is a perfect storm - one which will benefit 80M.

This is why I've put my money here and I'm relatively confident we see the SP push up more yet.

I'd expect traders to start positioning themselves soon, we should see a nice flurry of buys before the TU and if it's as positive as we are predicting, the SP could push up at pace

Some nice buys coming in now, this goes on a run post update. People building positions nicely

Market seems to have woken up at last here and a really good indication how it will respond to the inbound news. The company are now about to go all in on oncology and lost on Nasdaq.

I'd be gobsmacked if this didn't rally hard in the coming sessions.

Old news and already priced in.

Wow, a clear misunderstanding of Biotech Companies.

Investors on here clearly don't have much exposure to them because it's not about making money at this stage, it's about getting your product to a point where a big Pharma will come in and take over or you find a way of getting the product to commercialisation.

Despite this, AGL is in a very very good position whereby it has plenty of cash, debt free and an incredible product.

Settle down children, the petty insults and bad grammar stinks of playground antics.

This is a bb for HARL investors and if you're not invested here, move along. For those derampers with an agenda, the days of spreading doubt on these bb's no longer has an effect.

So let's keep discussions factual, balanced and unbiased.

Yes I know what cash burn is, but in any biotech co who are mainly R&D, cash burn is always going to be high.

It's all about developing the tech and either bringing it commercialisation or selling it for a handsome price.

AGL has enough cash to do it through to next year, so no requirement for a raise anytime soon. By that point, the hope is that they're taken over.

....on Biotech stocks. Far too many people concentrate on cash burn, rather than the tech / IP.

Almost all small or mid cap biotech companies don't make money, especially those in R&D. This is the whole point, they research, develop and if results are good, they usually are taken over.

It baffles me why people invest in R&D and expect profit.

I'm not in here but I'm in other biotech stocks. I do now see 31p being oversold and if it drops any further, I intend on buying in. Today's drop will have caught the eye of larger pharma's.

Good luck everyone

So many opinions on the SP decline but the one fact we know, is that there's more sellers than buyers ATM. Why is that? It's anyone's guess.

The SP will either rise significantly on positive drill results or drop further on bad results. At this point, it's very high risk - reward, so be careful.

Girdz,

when I say kind on us, that's exactly what I mean. A 5% premium on where the dust settles would be fine.

I know you use every chance to deramp - but try being balanced for once.

......BIDS wouldn't bother taking legal action if their 'robust pipeline' was anywhere near close to fruition.

The legal battle will be very lengthy and costly for BIDS. I've been invested here for a good while and have also traded it. I do believe in the company but management need a complete reshuffle.

I can see a raise coming soon - hopefully one that's kind on us all.

Am I actually reading this. OMG how cringey and childish hahahahahahahaha.

Come on guys, do us all a favour and grow up.

As for the wild predictions on the SP - it's being pushed and pulled by traders. There's no definitive way of knowing the next move but for what it's worth and from a fundamental perspective, it's looking good value at the current SP.

this one's going to sting today. It explains why the SP has been in a steady decline.

Oh well, we live and learn.

hard when the selling stops. No strong indication that the selling has stopped yet, so may drop further but with some buying volume we should see a great recovery.

It's hard to keep fundamentally good companies down.

Schroders are frequently trading, so it's likely they just need capital for elsewhere. I'm not overly concerned to be honest

explains the persistent dop in share price.

Anyone's guess when they'll stop but at least we know who it is now.

They wouldn't double their stake unless they were confident.

I'm sure they would have had a tip off for some big contract announcements inbound.

The market really is napping on this news.

Check out the squabbling and child's play. Anyone who thinks this is a dog's share shouldn't be trading or investing.

Fundamentals are very good and like most other fundamentally sound businesses ATM, they're in the same boat. The markets been illiquid for some time and things are starting to look better again.

SP is obviously frustrating but some director buying could be the catalyst to start an upwards trend again.